Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis
Felix J Hüttner, Lutz Schneider, Ignazio Tarantino, Rene Warschkow, Bruno M Schmied, Thilo Hackert, Markus K Diener, Markus W Büchler & Alexis Ulrich
This population-based analysis of stage IV P-NET patients provides compelling evidence that palliative resection of the primary tumor is associated with significant survival benefit. Thus, the recent recommendations judging resection of the primary as inadvisable and the accompanying trend towards fewer palliative resections of the primary tumor have to be contested.
|citation||Hüttner F J, Schneider L, Tarantino I, Warschkow R, Schmied B M, Hackert T, Diener M K, Büchler M W, Ulrich A. Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis. Langenbecks Arch Surg 2015; 400:715-723.|
|type||journal paper/review (English)|
|date of publishing||22-7-2015|
|journal title||Langenbecks Arch Surg (400/6)|